Both radioactive iodine and surgical removal of the thyroid in children with Graves' disease lead to permanent underactive thyroid at similar rates, meaning both treatments result in lifelong thyroid hormone replacement.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review of RCTs would definitively establish whether the rates of permanent hypothyroidism are truly equivalent between RAI and thyroidectomy by eliminating selection bias.
A systematic review and meta-analysis of all randomized controlled trials comparing radioactive iodine (150–200 mCi) versus total thyroidectomy in children aged 8–18 with Graves' disease, with primary outcome: permanent hypothyroidism defined by TSH >10 mIU/L and free T4 <0.7 ng/dL on levothyroxine-free testing at 5 years.
A randomized controlled trial would determine whether the two treatments cause equivalent rates of permanent hypothyroidism by eliminating confounding from treatment selection.
A multicenter, double-blind RCT enrolling 300 children aged 8–18 with Graves' disease failing medical therapy, randomized 1:1 to radioactive iodine (150 mCi) or total thyroidectomy, with primary outcome: permanent hypothyroidism at 5 years defined by TSH >10 mIU/L and free T4 <0.7 ng/dL without replacement, secondary outcomes: quality of life, cognitive function, and growth.
A prospective cohort study with standardized follow-up could strengthen the observed equivalence by reducing measurement and recall bias.
A prospective multicenter cohort study following 500 children aged 8–18 with Graves' disease treated with either RAI or thyroidectomy, with standardized thyroid function testing at 6, 12, 24, and 60 months, and hypothyroidism defined by TSH >10 mIU/L and free T4 <0.7 ng/dL without replacement, adjusting for age, dose, and baseline TSH.
A case-control study could identify whether children who developed hypothyroidism after RAI differed from those who did not, in terms of iodine uptake or dosing.
A matched case-control study comparing 200 children who developed permanent hypothyroidism after RAI with 200 who remained euthyroid, matched for age, RAI dose, and baseline TRAb, assessing pre-treatment thyroid uptake and post-treatment TSH trajectory.
A cross-sectional study could estimate the prevalence of hypothyroidism at a single time point across treatment groups, but cannot determine causality or progression.
A national cross-sectional survey of 1,000 children aged 8–18 with a history of Graves' disease treated with RAI or thyroidectomy, assessing current thyroid status and levothyroxine use at a single time point, stratified by treatment type and time since intervention.